In a 2-year carcinogenicity study in Sprague Dawley rats, subcutaneous doses of 0.0025, 0.01, 0.025 and 0.1 mg/kg/day were administered (below quantification, 0.2-, 0.4-, and 2-fold the exposure at the MRHD)
According to the Mounjaro FDA prescribing information, injection-site reactions redness, itching, swelling, or pain at the injection point occurred in approximately 3-7% of participants across the SURPASS clinical trials depending on dose
"It makes it look like the FDA-approved drug is still in shortage, when in fact pharmacies are making a business decision: 'We're not going to carry this,'" Brunner said
Functional and morphological changes in the hippocampal neuronal circuits associated with epileptic seizures
Specific affiliate pages (Blue Shield of California, BCBS of Michigan, BCBS of Texas, CareFirst, etc.) give the policy details for that particular Blue plan
Inhibition of fatty acid oxidation enables heart regeneration in adult mice